Shineco Inc. Acquires 51% Stake in Xi'an Dong'ao Health Management, Expanding Global Blockchain-Biotech Network

Reuters

Aug 20

Shineco Inc. Acquires 51% Stake in Xi'an Dong'ao Health Management, Expanding Global Blockchain-Biotech Network

Shineco Inc. has announced the acquisition of a controlling 51% stake in Xi'an Dong'ao Health Management Co., Ltd., a company specializing in cryogenic cell storage and clinical applications. This strategic acquisition supports Shineco's initiative to operationalize the tokenization of biological cellular assets by providing the necessary off-chain infrastructure for token redemption. This move, combined with their prior acquisition of Singapore-based Infiniclone, strengthens Shineco's global storage and infusion network, ensuring seamless on-chain and off-chain asset settlement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shineco Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN54480) on August 20, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2560035174"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2560035174\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2560035174?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-20 18:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2560035174","market":"us","top_or_hot":-1,"title":"Shineco Inc. Acquires 51% Stake in Xi'an Dong'ao Health Management, Expanding Global Blockchain-Biotech Network","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Shineco Inc. Acquires 51% Stake in Xi'an Dong'ao Health Management, Expanding Global Blockchain-Biotech Network\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Shineco Inc. has announced the acquisition of a controlling 51% stake in Xi'an Dong'ao Health Management Co., Ltd., a company specializing in cryogenic cell storage and clinical applications. This strategic acquisition supports Shineco's initiative to operationalize the tokenization of biological cellular assets by providing the necessary off-chain infrastructure for token redemption. This move, combined with their prior acquisition of Singapore-based Infiniclone, strengthens Shineco's global storage and infusion network, ensuring seamless on-chain and off-chain asset settlement.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shineco Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN54480) on August 20, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shineco Inc. Acquires 51% Stake in Xi'an Dong'ao Health Management, Expanding Global Blockchain-Biotech Network</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShineco Inc. Acquires 51% Stake in Xi'an Dong'ao Health Management, Expanding Global Blockchain-Biotech Network\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-20 18:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Shineco Inc. Acquires 51% Stake in Xi'an Dong'ao Health Management, Expanding Global Blockchain-Biotech Network\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Shineco Inc. has announced the acquisition of a controlling 51% stake in Xi'an Dong'ao Health Management Co., Ltd., a company specializing in cryogenic cell storage and clinical applications. This strategic acquisition supports Shineco's initiative to operationalize the tokenization of biological cellular assets by providing the necessary off-chain infrastructure for token redemption. This move, combined with their prior acquisition of Singapore-based Infiniclone, strengthens Shineco's global storage and infusion network, ensuring seamless on-chain and off-chain asset settlement.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shineco Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN54480) on August 20, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SISI","symbol_name":"尚高生命科学","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL3ntvPR:1","article_id":"2560035174","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2560035174","pubTimestamp":1755685856,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Shineco Inc. has announced the acquisition of a controlling 51% stake in Xi'an Dong'ao Health Management Co., Ltd., a company specializing in cryogenic cell storage and clinical applications. This strategic acquisition supports Shineco's initiative to operationalize the tokenization of biological cellular assets by providing the necessary off-chain infrastructure for token redemption. This move, combined with their prior acquisition of Singapore-based Infiniclone, strengthens Shineco's global storage and infusion network, ensuring seamless on-chain and off-chain asset settlement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shineco Inc. published the original content used to generate this news brief via PR Newswire  on August 20, 202","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SISI":"尚高生命科学","BK4183":"个人用品"},"translate_title":"Shineco收购西安东奥健康管理51%股权，拓展全球区块链-生物科技网","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SISI":0.9},"content_text":"Shineco Inc. Acquires 51% Stake in Xi'an Dong'ao Health Management, Expanding Global Blockchain-Biotech Network\n    \n\n        Shineco Inc. has announced the acquisition of a controlling 51% stake in Xi'an Dong'ao Health Management Co., Ltd., a company specializing in cryogenic cell storage and clinical applications. This strategic acquisition supports Shineco's initiative to operationalize the tokenization of biological cellular assets by providing the necessary off-chain infrastructure for token redemption. This move, combined with their prior acquisition of Singapore-based Infiniclone, strengthens Shineco's global storage and infusion network, ensuring seamless on-chain and off-chain asset settlement.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shineco Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN54480) on August 20, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}